Yüklüyor......
Bispecific antibodies targeting mutant RAS neoantigens
Mutations in the RAS oncogenes occur in multiple cancers, and ways to target these mutations has been the subject of intense research for decades. Most of these efforts are focused on conventional small-molecule drugs rather than antibody-based therapies because the RAS proteins are intracellular. P...
Kaydedildi:
| Yayımlandı: | Sci Immunol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8141259/ https://ncbi.nlm.nih.gov/pubmed/33649101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.abd5515 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|